Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Item

http://www.wikidata.org/entity/Q37150744

Q37150744

about

Oxidative Stress during HIV Infection: Mechanisms and Consequences Modeling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs Abnormal cardiac strain in children and young adults with HIV acquired in early life.Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats.Relaxation effect of abacavir on rat basilar arteries.Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells.Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries.Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats.Pulmonary arterial hypertension in human immunodeficiency virus infection.An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases.The changing epidemiology of HIV-infected patients in the intensive care unit.Mg supplementation protects against ritonavir-mediated endothelial oxidative stress and hepatic eNOS downregulation.Hyperglycemia exacerbates antiretroviral drug combination induced blood-brain barrier endothelial toxicity.The purine analogues abacavir and didanosine increase acetaminophen-induced hepatotoxicity by enhancing mitochondrial dysfunction.Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.In vitro and in vivo evaluation of dasatinib and imatinib on physiological parameters of pulmonary arterial hypertension.Drug-Mediated Gene Regulation of Vitamin D3 Metabolism in Primary Human Dermal Fibroblasts.Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells.Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals.The soybean isoflavonoid equol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells.The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes.High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.The antiretroviral protease inhibitor ritonavir accelerates glutathione export from cultured primary astrocytes.

P2860

Q28077167-404BABEC-DA44-4788-ACBC-A99BA92B7581 Q28478103-5FADCBAA-AACE-4377-B531-AF541B900EA8 Q30452923-B201B44C-CC00-49D3-B47F-552833AE5813 Q34082926-BCB73832-3A12-43BC-83CB-BD025158915F Q34333367-FD244BC0-F5CA-4F91-830C-9A0C2C65E519 Q35151656-49A5BDBE-6303-4227-85AE-36738E5AB810 Q35597616-55699602-EA90-4147-9726-83990365F6D9 Q35739410-60D64894-7692-47E6-8C29-B8AAFEB5B9BB Q35743832-D373C3B9-3DC4-46E8-9826-BA26D59DE029 Q35907288-A8555E0C-9C12-49F6-90FD-FD0ECB4C1601 Q36701580-37D9FC82-954A-48CF-AF5A-CF310DEE64FC Q36835027-3CF32484-73D1-4F0A-AF99-C7E62775570F Q37346036-26382D0D-73A5-42E3-B3BB-2FA9BA5FB569 Q37612691-5166F475-B4C6-4CCF-BFBA-0073E3041CF6 Q37848593-E0F7B89F-ACAC-4E92-AD7F-5CF725CF6765 Q37857545-F9A36859-F38D-4EB1-B6AB-351428686A22 Q38365945-7D5320B0-D230-4AA2-8FB9-F11901D983D9 Q38762179-3C2FED26-A6AC-453C-90E9-DE7E63D5C769 Q38805500-E6697463-6939-4139-A0DE-8061C028C11C Q38882614-67EECABB-1E0B-4D52-A4C4-42ADAFF43195 Q38913950-1E21BB97-4CFD-49C0-8C3C-9673CB5D47FD Q39610128-528AFE33-A31B-4109-B7FD-397B43306381 Q39613932-2F530B9E-FC01-4488-B604-48AACA6C93D0 Q40051820-2176C6E6-8965-49FB-B0D1-3C79A619AA7D Q40267454-E2C4897E-9907-4B50-A129-BDD09A8729BD Q41848164-13C7D2C9-2384-438B-AAF4-0C9C98419B19 Q44176745-65154AF6-C135-42C0-A244-E071D72736F9 Q44307756-7C8387D4-A4B5-4D7A-82E6-1ECA0610DF8D Q44797235-E2C5A63F-75A1-4375-B93F-4B93CFF6C4D3 Q48198876-8420C3B6-0E3D-4D0F-A419-76288D5AA302

P2860

Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells.

Item

http://www.wikidata.org/entity/Q37150744

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs